# Avantor Inc. – FDA Inspection, Aug 3, 2018

Source: https://www.keypedia.com/records/fda_inspections/avantor-inc/5740f839-13ca-4930-9581-fd28747e01c7
Source feed: FDA_Inspections

> FDA inspection 1064581 of Avantor Inc., August 03, 2018. Classification: No Action Indicated (NAI). 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1064581
- Company Name: Avantor Inc.
- Inspection Date: 2018-08-03
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1274956 - 2025-05-27](https://www.keypedia.com/records/fda_inspections/avantor-inc/bfed1d58-4a60-441b-a358-6c053302726b)
- FDA Inspection 1102121 - 2019-08-12
- FDA Inspection 1025358 - 2017-08-29
- FDA Inspection 855830 - 2013-11-15
- FDA Inspection 781182 - 2012-05-11

## Related Officers

- Issuing Officer
- Issuing Officer

Company: https://www.keypedia.com/companies/avantor-inc/d47a07ba-3a58-4e37-84ec-dd93b3d815db

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
